Annual Accounts Receivable
$119.50 K
+$112.50 K+1607.14%
December 1, 2023
Summary
- As of February 8, 2025, CYTO annual accounts receivable is $119.50 thousand, with the most recent change of +$112.50 thousand (+1607.14%) on December 1, 2023.
- During the last 3 years, CYTO annual accounts receivable has risen by +$119.50 thousand (+100.00%).
- CYTO annual accounts receivable is now at all-time high.
Performance
CYTO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$0.00
-$119.50 K-100.00%
June 1, 2024
Summary
- As of February 8, 2025, CYTO quarterly accounts receivable is $0.00, with the most recent change of -$119.50 thousand (-100.00%) on June 1, 2024.
- Over the past year, CYTO quarterly accounts receivable has dropped by -$35.40 thousand (-100.00%).
- CYTO quarterly accounts receivable is now -100.00% below its all-time high of $190.90 thousand, reached on June 30, 2022.
Performance
CYTO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CYTO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1607.1% | -100.0% |
| 3 y3 years | +100.0% | -100.0% |
| 5 y5 years | - | -100.0% |
CYTO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1607.1% | -100.0% | at low |
| 5 y | 5-year | at high | -100.0% | -100.0% | at low |
| alltime | all time | at high | -100.0% | -100.0% | at low |
Altamira Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $0.00(-100.0%) |
| Dec 2023 | $119.50 K(+1607.1%) | $119.50 K(+237.6%) |
| Jun 2023 | - | $35.40 K(+405.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $7000.00(-70.6%) | $7000.00(-96.3%) |
| Jun 2022 | - | $190.90 K(+702.1%) |
| Dec 2021 | $23.80 K(>+9900.0%) | $23.80 K(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Altamira Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Altamira Therapeutics?
- What is Altamira Therapeutics annual accounts receivable year-on-year change?
- What is Altamira Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly accounts receivable year-on-year change?
What is Altamira Therapeutics annual accounts receivable?
The current annual accounts receivable of CYTO is $119.50 K
What is the all time high annual accounts receivable for Altamira Therapeutics?
Altamira Therapeutics all-time high annual accounts receivable is $119.50 K
What is Altamira Therapeutics annual accounts receivable year-on-year change?
Over the past year, CYTO annual accounts receivable has changed by +$112.50 K (+1607.14%)
What is Altamira Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of CYTO is $0.00
What is the all time high quarterly accounts receivable for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly accounts receivable is $190.90 K
What is Altamira Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, CYTO quarterly accounts receivable has changed by -$35.40 K (-100.00%)